BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,045 filers reported holding BAXTER INTL INC in Q4 2017. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $301,543 | -56.3% | 7,990 | -47.3% | 0.03% | -51.7% |
Q2 2023 | $690,690 | +9.4% | 15,160 | -2.6% | 0.06% | +3.6% |
Q1 2023 | $631,438 | -19.8% | 15,568 | -4.2% | 0.06% | -22.2% |
Q4 2022 | $787,555 | -12.9% | 16,255 | -3.2% | 0.07% | -22.6% |
Q3 2022 | $904,000 | -18.0% | 16,785 | -2.2% | 0.09% | -13.1% |
Q2 2022 | $1,102,000 | -25.8% | 17,161 | -10.4% | 0.11% | -17.7% |
Q1 2022 | $1,486,000 | -13.8% | 19,163 | -4.5% | 0.13% | -6.5% |
Q4 2021 | $1,723,000 | +5.8% | 20,069 | -0.8% | 0.14% | +0.7% |
Q3 2021 | $1,628,000 | +44.7% | 20,241 | +44.8% | 0.14% | +70.4% |
Q2 2021 | $1,125,000 | -5.6% | 13,981 | -0.0% | 0.08% | -1.2% |
Q1 2021 | $1,192,000 | +11.2% | 13,983 | +4.6% | 0.08% | +2.5% |
Q4 2020 | $1,072,000 | +2.3% | 13,362 | +4.4% | 0.08% | +3.9% |
Q3 2020 | $1,048,000 | +1.1% | 12,803 | +5.3% | 0.08% | -6.1% |
Q2 2020 | $1,037,000 | -6.7% | 12,164 | -1.5% | 0.08% | -9.9% |
Q1 2020 | $1,112,000 | +4.6% | 12,349 | -2.9% | 0.09% | +11.0% |
Q4 2019 | $1,063,000 | -5.5% | 12,715 | -1.1% | 0.08% | -8.9% |
Q3 2019 | $1,125,000 | +4.1% | 12,858 | -2.6% | 0.09% | -6.2% |
Q2 2019 | $1,081,000 | +0.6% | 13,198 | -0.2% | 0.10% | +17.1% |
Q1 2019 | $1,075,000 | +22.2% | 13,218 | -1.1% | 0.08% | +15.5% |
Q4 2018 | $880,000 | -52.0% | 13,369 | -43.8% | 0.07% | -48.2% |
Q3 2018 | $1,833,000 | +1.7% | 23,774 | -2.7% | 0.14% | -1.4% |
Q2 2018 | $1,803,000 | +99.4% | 24,422 | +75.7% | 0.14% | +93.1% |
Q1 2018 | $904,000 | -2.3% | 13,899 | -2.9% | 0.07% | 0.0% |
Q4 2017 | $925,000 | – | 14,317 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Point | 36,000,000 | $2,658,240,000 | 18.52% |
SECTOR GAMMA AS | 721,058 | $53,243,000 | 8.85% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,747,061 | $202,843,000 | 5.38% |
Veritas Asset Management LLP | 8,852,005 | $653,632,000 | 5.36% |
Knowledge Leaders Capital, LLC | 79,384 | $5,862,000 | 4.39% |
HealthCor Management, L.P. | 1,800,000 | $132,912,000 | 4.22% |
Progressive Investment Management Corp | 79,282 | $5,854,000 | 3.78% |
13D Management LLC | 200,318 | $14,791,000 | 3.77% |
ARGENT CAPITAL MANAGEMENT LLC | 1,288,236 | $95,123,000 | 3.42% |
Chiron Investment Management, LLC | 612,787 | $45,248,000 | 3.12% |